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Abstract: Musculoskeletal pain is common in the general pediatric population and is a challenge to
youth, their parents, and society. The majority of children experiencing musculoskeletal pain will
recover; however, a small subgroup of youth develops chronic pain. There is limited understanding
of the factors that affect the transition from acute to chronic pain in youth. This review introduces
sleep deficiency in the acute to chronic pain transition, exploring the potential mediational or
mechanistic role and pathways of sleep in this process, including the interaction with sensory,
psychological, and social components of pain and highlighting new avenues for treatment. Biological
mechanisms include the increased production of inflammatory mediators and the effect on the
hypothalamus-pituitary-adrenal (HPA) axis and on the dopaminergic signaling. Psychological and
social components include the effect of sleep on the emotional-affective and behavioral components
of pain, the negative impact on daily and social activities and coping strategies and on the reward
system, increased pain catastrophizing, fear of pain, pain-related anxiety, hypervigilance, and social
isolation. Future longitudinal studies are needed to elucidate these mechanistic pathways of the
effect of sleep on the transition from acute to chronic pain, which may lead to the development of
new treatment targets to prevent this transition.
Keywords: sleep; acute pain; adolescents; chronic pain
1. Introduction
Musculoskeletal pain is common in the general pediatric population, with prevalence
estimates of up to 40% in children and adolescents [1]. Most children with acute muscu-
loskeletal pain recover [2]. However, up to 40% of adolescents develop musculoskeletal
pain still present 5 years after onset [1,3]. Furthermore, rates of chronic pain are increasing,
which places an increasing burden on both individuals and society [4,5]. The global impact
of musculoskeletal pain in youth is underlined by back and neck pain, which are among the
top 10 leading causes of years lived with disability (YLDs) in the world for adolescents [6].
This burden may be reduced if we successfully identify patient-related factors driving the
transition from acute to chronic pain [2,7]. This knowledge could allow for the design and
implementation of strategies aimed at preventing chronic pain.
While research on modifiable factors that might influence the transition from acute
to chronic musculoskeletal pain [8,9] is rapidly evolving, current conceptual models of
the transition from acute to chronic pain miss a potentially important modifiable factor in
children and adolescents: sleep deficiency [10]. Sleep deficiency refers to problems in sleep
quality or quantity and is a known predictor of acute pain following injury [11]. Sleep
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deficiency is common in children and adolescents, with prevalence estimates between
25% and 40% [12,13]. Moreover, sleep patterns have changed over the past few decades,
and children now sleep 1 h less per day in most Western countries compared to 100 years
ago [14]. Sleep has far ranging implications for children’s health and well-being.
Adolescence is a particular stage of life where a remodeling in sleep architecture
occurs, with a reduction in slow wave sleep and rapid eye movement (REM) sleep. A shift
in the biological mechanisms which modulate the circadian rhythms and sleep pressure
occurs in adolescence, which coincides with a change in social activities, both resulting
in later bedtimes [15]. Sleep deficiency has consistently been associated with chronic
musculoskeletal pain in children and adolescents [16–18]. Indeed, 50–60% of adolescents
with chronic pain problems report sleep deficiency [17]. The relationship between sleep
deficiency and chronic pain has often been described as bi-directional, although evidence
suggests that sleep is a stronger predictor of pain rather than vice versa [19–21]. However,
despite this knowledge, sleep disturbance is not included in existing conceptual models
of acute to chronic pain transition. Therefore, the aims in this narrative review are to
(1) explore the potential mediational or mechanistic role and pathways of sleep in the acute
to chronic pain transition, (2) briefly describe the current evidence regarding treatments for
sleep problems in youth, and (3) provide an agenda for future targeted research in this area.
2. Methods
A literature search was performed for the present narrative review. Original research
and review articles related to the topic of this review were searched in the major electronic
scientific databases (e.g., PubMed, Google Scholar) and summarized. Search terms entered
in the scientific databases included: “sleep”, “acute pain”; “adolescents”; “chronic pain”,
“musculoskeletal pain”; “mechanisms”; “mediation”; “transition”; “sleep treatment”; “psy-
chological”; “affect”; “social”. Articles for which the full text was not available and were
not in English or any other language for which the authors could provide translation (i.e.,
Italian, Spanish or Scandinavian languages) were excluded. The articles retrieved were
complemented with articles already in possession of the authors of this review.
3. The Transition from Acute to Chronic Pain
While a full description of pain pathways is beyond the scope of this review, it is
important to consider that noxious signals associated with acute musculoskeletal pain are
carried via Aδ-and C-fibers to the dorsal horn of the spinal cord and then via ascending
spinal neurons to the central nervous system, including the central sensory cortex [22,23].
In turn, the sensation of pain is modulated by a parallel descending pain inhibitory system.
Maladaptive processes in any part of this pain pathway may drive acute to chronic pain
transition [22–24] as described by Elman and Borsook [2,10], who constructed a model that
describes the transition from acute to chronic pain by drawing partially from addiction
neurobiology research. This model explains how contributory processes in the peripheral
and central nervous system, including sensory, psychological (e.g., cognitions, emotions
and motivations), and social components (e.g., interpersonal interactions), play a role in
the evolution from tissue or nerve injury (initiating event), as detected by nociceptors
(acute pain), in the transition to chronic pain [2,10]. According to this model, changes in
the spinal cord and central nervous system would occur, which can result in hyperalgesia,
allodynia, and a negative affect, as well as changes in several brain circuitries involved
in this transition [10]. A key brain circuitry involved is the reward system. A feature
of the reward system is the change in dopamine levels, which is also observed in pain
conditions, although with differences between acute and chronic pain. Acute pain results
in the activation of the reward system, which leads to a contingent increase in the levels of
dopamine in brain regions such as the nucleus accumbens and the medial prefrontal cortex.
This change in dopamine levels is modulated by mood, emotions, memory, stress, and also
by the amygdala’s activity, which is responsible for providing an hedonic value and creating
a memory of the pain event [2,10]. Other elements of reward also regulate the dopamine
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release, such as the opioid neurotransmission system and the homeostatic system, which
compares the dopamine level to a threshold and serves as a biofeedback, thus modulating
the dopamine production [10]. However, after prolonged dopamine production, the
homeostatic system might become dysfunctional, resulting in neuroadaptations of the
reward circuitry and impaired sensory, psychological, behavioral, and social functions
leading to the development of chronic pain [10]. A number of other pathways are also
described in this model. Despite its comprehensiveness, sleep was not included in this
model, perhaps due to a lack of research attention at the time of its development.
4. The Potential Role of Sleep in the Transition from Acute to Chronic Pain
Recent advances give a plausible explanation for how the inclusion of sleep may
extend the model developed by Elman and Borsook. In the following paragraphs, we
describe evidence highlighting how biological (Section 4.1), psychological (Section 4.2),
and social (Section 4.3) components interact with sleep and pain to drive chronic pain
development [19]. A summary of the effect of sleep deprivation on these components is
outlined in Figure 1. Specific mechanisms that might explain the transition are further
outlined within the following sections.
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4.1.1. Evidence on the Effect of Sleep on the Sensory Component of Pain
Evidence (mainly from studies in adult populations) has shown that pain processing
is altered in individuals who are sleep-deprived, with resulting lower pain thresholds
and increased pain sensitivity [19,25]. A recent meta-analysis including 11 experimental
studies of healthy adult individuals showed that sleep deprivation increases self-reported
pain perception and influences pain responses to somatosensory tests (e.g., pressure pain
thresholds, heat pain thresholds, cold pain thresholds) [25]. A more recent study (not
included in that meta-analysis) showed impaired conditioned pain modulation, increased
pain sensitivity to pressure and cold pain, and facilitated temporal summation of pain in
young healthy adults after 24 h of total sleep deprivation [26]. Despite the body of evidence
primarily originating from adult populations, new research indicates these findings are
also applicable to the adolescent population. Recently, Krietsch showed in a three-week
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cross-over experimental study in which adolescents also reported greater frequency of pain
complaints following 5 nights of insufficient sleep [27].
4.1.2. Mechanisms to Explain the Effect of Sleep on the Sensory Component of Pain
There are several potential biological mechanisms contributing to the sleep-pain
association. This might involve the increased production of inflammatory mediators
such as prostaglandins and cytokines, observed in sleep-deprived individuals, as well
as in different pain conditions [28]. Other substances such as serotonin, norepinephrine,
and adenosine, as well as the orexinergic system, might be involved. These substances
modulate pain but also regulate the sleep-wake cycle [15,28–30]. Findings from both
human and animal studies suggests that sleep deprivation might lead to the alteration of
the serotonergic system’s functioning [28,30]. This would impair the functioning of the
serotoninergic descending inhibitory system and decrease the pain threshold [30]. However,
it should be noted that there are differences between the effect of acute (increased serotonin
production) and chronic (reduced sensitivity of serotonin 1A receptor) sleep deprivation,
and further studies are needed [28]. Norepinephrine promotes wakefulness, and increased
norepinephrine levels are observed in sleep-deprived individuals [28]. However, how
norepinephrine can lead to pain in sleep-deprived individuals has not been clarified yet, as
previous preclinical studies suggest that higher norepinephrine levels are associated with
an analgesic effect [28]. Adenosine regulates sleep, and adenosine levels increase during
prolonged wake time. Findings from studies in rats showed that increased adenosine levels
were associated with both sleep deprivation and hyperalgesia, suggesting that increased
adenosine levels might mediate the effect of sleep on pain [28]. The orexinergic system
includes two neuropeptides (orexin A and B). Increased orexin activity is associated with
the wake status; in addition, the orexinergic system is also involved in the modulation of
pain. Therefore, it has been proposed as a mediator of the effect of sleep deprivation on
pain, although further studies are needed to elucidate this [28].
While a detailed discussion of these systems is beyond the scope of this review, they
share the common characteristics of being proinflammatory in response to acute muscu-
loskeletal injury and, in turn, further activated in response to sleep deprivation. In addition,
the functioning of the hypothalamus-pituitary-adrenal (HPA) axis is involved in the re-
sponse to physical and psychological stress, and also in the regulation of sleep [15,28,31].
Acute musculoskeletal injury triggers the amygdala in the activation of the HPA axis,
resulting in the production of cortisol, a stress-response hormone which is normally rapidly
cleared from the body once stress resolves [15,28,31]. However, a maladaptive response
to acute stress may cause a prolonged stimulation of the HPA axis, which in the long-
term could become dysfunctional and hyper-reactive to stressful stimuli. This has been
observed in chronic pain conditions and also in individuals with insomnia, who showed
greater cortisol production and an over-reactivity of the HPA axis, which mediated the
association between sleep deficiency and pain sensitivity [28,31–33]. Another potential
mechanism involves the dopaminergic signaling system, which is central to pain transmis-
sion. Endogenous dopamine production is associated with analgesia in the presence of
acute pain [34–36]. However, dopamine function is reduced by sleep disruption [28], which
may contribute to the hypodopaminergic state found in some individuals with chronic
pain [10,36]. Lastly, sleep deficiency also affects the opioidergic system, which could play
a role in acute to chronic pain transition. Evidence suggests a bi-directional relationship
between sleep deprivation and opioid use [29]. In individuals with acute pain following
injury or surgery, sleep deprivation could predispose them to a maladaptive descending
inhibitory control of pain involving the opioidergic system (i.e., downregulation of µ and
δ opioid receptors and reduced basal levels of endogenous opioid levels in the central
nervous system) [19,37–44], leading to increased opioid use for uncontrolled pain, while
increased prescription opioid use could disrupt sleep architecture and increase daytime
sleepiness and somnolence [29,45–47]. Furthermore, sleep disturbance is a hallmark of
chronic opioid use, contributes to opioid withdrawal, and is an important reason for re-
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lapse in those recovering from opioid abuse [48,49]. The above-described mechanisms are
summarized in Table 1.
Table 1. Summary of mechanisms to explain the effect of sleep on the sensory component of pain.
Proposed Mechanism Relationship with Sleep Relationship with Pain
↑ Inflammatory mediators
(prostaglandins, cytokines) ↑ Prostaglandins, cytokines after SD ↑ Prostaglandins, cytokines in pain conditions
Altered serotonergic system
↑ Serotonin (acute SD)
↓ Serotonin 1A receptor sensitivity
(chronic SD)
Impaired serotonergic descending inhibitory
system
↓ Pain threshold
↑ Norepinephrine ↑ Norepinephrine after SD Not clear yet
↑ Adenosine ↑ Adenosine after SD ↑ Adenosine associated with hyperalgesia
↑ Activity orexinergic system ↑ Activity orexinergic system after SD Pain modulation
HPA axis ↑ HPA axis reactivity after SD ↑ HPA axis reactivity in chronic pain
Dopaminergic signaling ↓ Dopamine after SD ↓ Dopamine in chronic pain
Opioidergic system ↓ Endogenous opioids after SD↓ µ and δ opioid receptors
Impaired opioidergic descending inhibitory
system
SD = Sleep deprivation; HPA axis = Hypothalamus-pituitary-adrenal axis; ↑ = Increased; ↓ = Decreased.
4.2. Sleep and Psychological Factors
4.2.1. Evidence on the Effect of Sleep on the Psychological Component of Pain
Sleep deficiency, psychological distress (e.g., depression, anxiety, stress) and chronic
pain often co-occur [15,17,35]. Sleep deficiency can directly influence mood and affect,
including increasing levels of depression, anxiety, and stress and by affecting cognitive
and emotional pathways, as sleep itself regulates emotions and motivation [15,34,50–52].
Recent evidence suggests that the interaction between sleep and psychological factors
can affect the transition from acute to chronic pain. Prior reviews of adult studies found
that negative affect mediated the relationship between sleep and pain [19,33,36]. The
evidence in children is less exhaustive. In a cross-sectional study with children with
chronic pain the association between poor sleep quality and pain was partially mediated by
negative affect (but not positive affect) [53]. In a longitudinal study in children with sickle
cell disease the association between poor sleep quality and pain intensity was partially
mediated by negative mood [54]. Another study (cross-sectional) including children
with chronic pain showed that the association between sleep quality and pain outcomes
(intensity, interference) was partially mediated by anxiety and depression [55]. Results from
a longitudinal study including children with polyarticular arthritis suggest that decreased
positive affect (e.g., cheerfulness, calmness) may mediate the relationship between sleep
and chronic pain [56]. High levels of pain catastrophizing experienced in individuals with
acute pain and sleep deficiency have been proposed as a mediator of the transition to
chronic pain [15,36], but no studies in children have tested this hypothesis by means of
mediational analysis.
4.2.2. Mechanisms to Explain the Effect of Sleep on the Psychological Component of Pain
There are multiple pathways by which the effect of sleep on psychological factors af-
fects acute pain perception and the transition to chronic pain [15,36]. Potential mechanisms
include an effect of negative mood on the emotional-affective and behavioral components
of pain that would lead to a decrease in the pain threshold [30] and a negative impact on the
engagement in daily activities and an increased use of maladaptive coping strategies [15].
Cognitive appraisals such as pain catastrophizing, where sleep deprivation is caused by
excessive rumination and, in turn, worse sleep increases catastrophizing thoughts about
pain, might be another important psychological factor influencing the transition to chronic
pain in youth, as observed in adults with chronic pain [15,36].
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In addition, sleep deprivation affects the reward system, with differences between
acute (increased motivation for reward) and chronic sleep deprivation (which might lead
to both an increase or a decrease in motivation for reward) [34,50]. A dysfunctional
reward system might therefore predispose to the development of chronic pain. Neuro-
transmitters involved in mood/affect, sleep, and pain include the dopaminergic signaling
pathway [35] and 5-hydroxytryptamine (5-HT) neuromodulators [30]. These neuromodula-
tors are involved in the modulation of the nociceptive stimulus, and a decreased functional
availability observed in depressive mood, sleep deficiency, and chronic pain status might be
another pathway for the role of sleep and depression in the transition from acute to chronic
pain [19,30,35]. The amygdala activation might be another pathway. The amygdala is
involved in pain modulation and in creating an emotional link to pain when a painful event
occurs. Sleep deprivation affects the amygdala activity, which becomes hyperactive during
sleep deprivation but also in depressed individuals [15,30,34]. It has been proposed that
both positive and negative emotional states (stress, anxiety, and depression) might have a
role in modulating the perception of pain through the amygdala. Negative emotions would
lead to increased pain through the activation of the amygdala, while positive emotions
would inhibit the amygdala and decrease pain [15]. A summary of these mechanisms is
outlined in Table 2.
Table 2. Summary of mechanisms to explain the effect of sleep on the psychological component of pain.
Proposed Mechanism Relationship with Sleep Relationship with Pain
Emotional component of pain Negative mood after SD affects the emotionalcomponent of pain ↓ Pain threshold due to high negative mood
Coping strategies Maladaptive coping after SD ↑ Pain perception due to maladaptive copingstrategies
Engagement in daily activities ↓ Engagement in daily activities after SD ↓ Engagement in daily activities linked topain
Catastrophizing ↑ Catastrophizing after SD ↑ Focus on pain due to catastrophizing
Reward ↑ Motivation after acute SD↑ or ↓ motivation after chronic SD
Dysfunctional reward associated with
chronic pain
5-HT neuromodulators ↓ 5-HT both in depression and after SD ↓ 5-HT in chronic pain
Dopaminergic signaling ↓ Dopamine both in depression and after SD ↓ Dopamine in chronic pain
Amygdala
↑ Amygdala activity in negative emotional
states and after SD
↓ Amygdala activity in positive emotional
states
↑ Amygdala activity - increased pain
↓ Amygdala activity - decreased pain
SD = Sleep deprivation; ↑ = Increased; ↓ = Decreased.
4.3. Sleep and Social Factors
4.3.1. Evidence on the Effect of Sleep on the Social Component of Pain
Sleep deprivation can affect daily life for youth in terms of social interactions, isolation,
loneliness, and the ability to carry out normal daily activities [15,57]. For example, in ob-
servational studies in adolescents, sleep deficiency was associated with a decreased ability
to carry out activities in the domains of school, recreation, and social activities [58,59].
Conversely, improved bedtime routines, better sleep quality, and later school times were
associated with improved school attendance and social functioning in children and adoles-
cents [60–62]. The presence of pain itself can also result in a reduced frequency of social
activities and therefore in more difficulties in developing or maintaining strong peer rela-
tionships, a higher dependency on the support of the family, and limitations in performing
daily activities and physical activity [63,64]. Individuals experiencing musculoskeletal
pain might also experience more restrictions in attending school, further straining social
relationships [63,64]. In turn, factors related to the social sphere (e.g., social isolation, social
functioning, loneliness) are associated with increased pain perception, musculoskeletal
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pain frequency, and lower levels of physical function [65,66]. This might result in the
creation of a vicious cycle between musculoskeletal pain and social isolation [64]. The
limitations in daily activities and reduced social interactions experienced by individuals
with pain can be further exacerbated by sleep deprivation, as shown in previous stud-
ies [67]. However, studies in children specifically assessing social factors as mediators of
the association between sleep and chronic pain have not been conducted yet, and further
studies are needed.
4.3.2. Mechanisms to Explain the Effect of Sleep on the Social Component of Pain
There are different proposed mechanisms to explain how the effect of sleep depriva-
tion on social components influences the transition from acute to chronic musculoskeletal
pain. Sleep deprivation exacerbates the negative reactivity to emotional stimuli and in-
creases social isolation in individuals with acute pain [57,58]. The amygdala activation
is a potential mechanism to explain the transition to chronic pain in children with acute
pain who experience social isolation and increased emotional reactivity. Studies have
shown hyper-activation of the amygdala in response to emotional stimuli in sleep-deprived
individuals [57]. Increased amygdala activity has also been associated with the loss of reg-
ulatory control and excessive emotional sensitivity [34]. The increased amygdala activity
may thus increase the attention toward pain, through its effect on the reward system. In
addition, the negative regulation of emotional stimuli and social isolation may further inter-
fere with a youth’s ability to cope with pain and increase pain perception, thus potentially
driving the transition from acute to chronic pain [15]. Sleep deprivation might further im-
pair a youth’s ability to perform meaningful daily activities (including social, recreational,
and physical activity) [3,59,68]. In the long-term, this might lead to greater disability and
the development of chronic musculoskeletal pain [3]. In addition, co-occurring pain and
sleep deprivation might result in persistent fatigue and lack of concentration [69]. This
can lead to further disability in youth and contribute to the development of chronic pain.
Additionally, sleep deprived youths who are more socially isolated might experience more
difficulties in ignoring pain and might develop behaviors that lead to an increased focus
on pain (i.e., fear of pain, pain-related anxiety, and hypervigilance, as proposed by the
Fear-Avoidance model of pain) [33,69,70] and to the avoidance of social activities that are
perceived as painful [59,67] and would affect coping strategies. Overall, this can contribute
to the maintenance of pain and disability [10,69,70]. The above-described mechanisms are
summarized in Table 3.
Table 3. Summary of mechanisms to explain the effect of sleep on the social component of pain.
Proposed Mechanism Relationship with Sleep Relationship with Pain
Maladaptive coping Maladaptive coping after SD in sociallyisolated children ↑ Pain perception
↓ Engagement in daily activities ↓ Engagement in daily activities after SD andsocial isolation ↑ Disability and chronic pain
Fatigue ↑ Fatigue after SD ↑ Disability and chronic pain
Fear-avoidant behaviors ↑ Fear-avoidant behaviors after SD ↑ Disability and chronic pain
Amygdala ↑ Amygdala activity after SD in sociallyisolated children
↑ Attention to pain due to:
↑ emotional sensitivity
↓ regulatory control
SD = Sleep deprivation; ↑ = Increased; ↓ = Decreased.
5. The Role of Sleep Treatments
While not yet studied in the context of preventing acute to chronic pain transmission
in youth, several sleep treatments could be helpful in this context. These include cognitive-
behavioral interventions and pharmacotherapy, which should be tailored to the specific
type of sleep problem and might be used alone or in combination [62,71,72]. A brief
Children 2021, 8, 241 8 of 12
summary of these treatments is outlined below with a focus on the treatment of insomnia,
which is the most common sleep complaint among youths with pain [16,72].
5.1. Cognitive-Behavioral Interventions
Cognitive-behavioral Therapy for Insomnia (CBT-I) is the gold standard treatment for
adults experiencing insomnia and can be modified for older children and adolescents [16,72].
CBT-I is a multicomponent treatment, targeting a range of cognitive, behavioral, and social
factors that may perpetuate insomnia, such as poor sleep hygiene practices (e.g., too much
time in bed, watching TV in bed) and negative attitudes about sleep (e.g., concern about
daytime deficits) [16,71,72]. The core behavioral skills are stimulus control and sleep
restriction. Stimulus control involves keeping a regular sleep schedule with sleep limited
to the night time, in addition to the improvement of the bed-sleep association (e.g., going to
bed only when sleepy, using the bed only for sleep and not for other stimulating activities
such as watching TV and social media) [62,71,72]. Sleep restriction involves creating a
sleep window to increase the time spent asleep while in bed and minimizing the time
spent awake in bed. This is accomplished by temporarily reducing the length of the sleep
period (based on sleep diaries indicating sleep and wake times). The aim is to improve the
association between bed and sleep (going to bed only when almost asleep) and increase
sleep efficiency [62,71].
Relaxation techniques include meditation, deep breathing, and muscle relaxation
and imagery, which consists in visualizing positive images such as relaxing scenes [71,72].
Strategies to improve sleep hygiene may focus on establishing a night-time routine and a
regular sleep schedule with a consistent wake-up time, sleeping in a cool, dark and quiet
environment, avoiding the consumption of food and drinks that contain caffeine, and
avoiding screen time before sleep [13,62].
While there is robust evidence for both the short-term and long-term improvements
in sleep following CBT-I in adults, there has been fewer studies of CBT-I conducted in
adolescents [13,71]. A recent systematic review of randomized controlled trials (RCTs) of
CBT-I among adolescents reported improvements in subjective (perceived sleep quality)
and objective sleep parameters (total sleep time, sleep onset latency, and sleep efficiency).
However, the RCTs had several limitations, such as a small sample size, a short follow-up,
and the exclusion of adolescents with comorbid physical and mental health conditions [73].
Preliminary new evidence shows that CBT-I can be adapted for populations with chronic
pain, with promising results [16]. In a pilot trial including adolescents with insomnia and
comorbid physical or psychological difficulties (chronic pain, anxiety, and depression),
CBT-I was associated with significant moderate to large improvements in self-reported
measures of sleep, anxiety, depression, and quality of life, and the effects were maintained
after 3 months [74]. In that trial, the CBT-I protocol included four sessions (max. 75 min
each) delivered over 4 to 6 weeks, in addition to the completion of a sleep diary during the
study period. The intervention strategies were: sleep education, sleep hygiene training,
sleep restriction, and stimulus control [74]. In another pilot trial including adolescents with
headache and insomnia, hybrid CBT-I (targeting both sleep and headache) improved sleep
and reduced headache frequency at a 3-month follow-up [75]. The protocol comprised
six sessions including core CBT-I strategies (stimulus, control, sleep restriction, sleep
hygiene training) and headache education, relaxation training, pleasant activity scheduling
and positive thought tracking, and parent operant training (to improve adolescent skills
practice). The results of this trial are in line with other hybrid interventions tested in adults
including both sleep and pain treatment components [76].
5.2. Pharmacotherapy
Pharmacotherapy (both over-the-counter and prescribed medication) is commonly
used to treat pediatric sleep disturbances and may include sleep medications such as
benzodiazepine receptor agonists (zolpidem, zaleplon, and eszopiclone), alpha agonists
(clonidine, guanfacine), antihistamines, melatonin, and chloral hydrate [62,71,72]. How-
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ever, it is not recommended as a first-line strategy for the treatment of sleep problems,
due to the lack of evidence on the long-term efficacy and safety of pharmacotherapy for
sleep in children and adolescents, despite the common use [72,77]. Indeed, there are
concerns regarding potential risks of dependency, rebound effects, addiction, and with-
drawal complications of these medications [77]. Therefore, recommendations are to limit
pharmacotherapy and use only together with other behavioral approaches [62,71].
6. Limitations
This narrative review has several limitations. A systematic approach was not used
for searching the evidence base, which would have enabled an unbiased selection of the
literature. In addition, only a few scientific databases were searched. Therefore, it might be
argued that some literature on potential mediators of sleep in the transition from acute to
chronic pain were not found and discussed. However, this is unlikely, as we included and
discussed evidence from the most recent reviews on sleep and pain.
7. Research Agenda for Future Investigations
We propose that future research focus on understanding the role of sleep in the
transition from acute to chronic musculoskeletal pain in children and adolescents. Several
specific topics warrant further investigation:
1. Longitudinal or experimental studies are needed to understand the mediational role
of modifiable social and psychological factors on the effect of sleep in the transition
from acute to chronic musculoskeletal pain. The evidence for social and psycho-
logical factors in children and adolescents is based on only a few cross-sectional
studies [53,55] and longitudinal studies [54,56]. Additional longitudinal studies are
needed to evaluate the temporal and causal relationships between sleep, social and
psychological factors, and subsequent acute to chronic pain transition. This knowl-
edge would allow for a better understanding of the temporal sequence of mechanisms
underlying the sleep-pain association, and identify mediators that may be targeted by
interventions in order to prevent the development of chronic pain (e.g., reducing so-
cial isolation). Investigations of youth following musculoskeletal injury may provide
the ideal means to prospectively study these factors over the course of the evolving
pain experience.
2. Further research is needed to clarify the role of biological factors by means of experi-
mental studies that assess the change in inflammatory mediators (e.g., prostaglandins,
cytokines), other substances and neurotransmitters (serotonin, norepinephrine, adeno-
sine, orexin), and HPA axis functioning and their association with pain in children
with sleep deficiency. This would allow for a better understanding of the role of
biological mechanisms in the transition to chronic pain and their specific intersection
with sleep.
3. There is also an urgent need for research evaluating whether existing treatments
aimed at improving sleep in youth may extend to the context of preventing acute to
chronic pain transition. For example, CBT-I has shown efficacy for sleep improvement
in multiple pain populations [16], but its role in preventing acute to chronic pain
transition remains unexplored.
8. Conclusions
This review has described the role of sleep in the transition from acute to chronic
pain in youth. In light of the profound negative effects of sleep deficiency on youth health
and functioning, future research efforts should focus on sleep as a potentially important
target for intervention to prevent the transition from acute to chronic pain. Potential
mechanistic pathways of the effect of sleep on this transition have been outlined and cover
biological, psychological, and social factors that could be targeted to prevent the transition
from acute to chronic pain. Future longitudinal studies with multiple time-points are
needed to elucidate the mechanisms through which sleep affects the transition from acute
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to chronic pain. The evidence regarding treatment options for sleep is presented and future
research should focus on therapies targeting both sleep and pain in adolescent populations
to prevent the transition from acute to chronic pain.
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